Lung Cancer News
🇺🇸 FDAFDA breaking news and regulatory updates for BD, investors, and analysts
Showing 1–11 of 11 articles
Arcus Biosciences pipeline update: casdatifan, quemliclustat, domvanalimab
kidney cancer · 4 min
Dr. Sarah MitchellChina’s Rise in Drug Development Looms Over U.S. Oncology Market
FDA · oncology · 5 min
Dr. Sarah MitchellChina Approves HERNEXEOS for Lung Cancer Treatment
China · oncology · 2 min
Dr. Sarah MitchellAmgen Inc Stock: Lung Cancer Setback Meets Steady Cash Flow
lung cancer · 3 min
Dr. Sarah MitchellSummit Therapeutics Ivonescimab Shows Overall Survival Benefit in Lung Cancer, ASCO 2026 Plenary Data Expected
Non-Small Cell Lung Cancer (NSCLC) · 3 min
Dr. Priya NandakumarASCO 2026: Top Oncology Trials to Watch
oncology · 5 min
Dr. Sarah MitchellPfizer Presents LORBRENA and BRAFTOVI Cancer Trial Updates at ASCO 2026
2 min
Michael RiveraRevolution Medicines Presents Updated Zoldonrasib Phase 1 Data for KRAS G12D Lung Cancer at AACR 2026
2 min
James Chen, PharmDBoehringer Ingelheim's Zongertinib Shows Promise for HER2-Mutant Lung Cancer in NEJM Study
Non-small cell lung cancer (NSCLC) · 3 min
James Chen, PharmDFDA Approves Tecentriq for Extensive-Stage Small Cell Lung Cancer
FDA · oncology · 4 min
Dr. Sarah MitchellFDA Grants Priority Review to Sotorasib for KRAS G12C NSCLC
FDA · non-small cell lung cancer · 4 min
Dr. Sarah MitchellExplore intelligence